Clinical Trial Update: Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gefitinib with pemetrexed/cisplatin in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gefitinib (Gefitinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Fudan University | Conditions: Toxicity, Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN